| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
1998-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100552434-B1 |
| titleOfInvention |
Preventive and/or therapeutic agent for renal failure |
| abstract |
The present invention provides a prophylactic and / or therapeutic agent for renal disease comprising a Tumor Cytotoxic Factor (TCF-II) variant incorporating a point mutant as an active ingredient.n n n As the TCF-II variant, the amino acid sequence Arg-Lys-Arg-Arg from the N-terminus 2 is mutated to Ala-Ala-Ala-Ala or the amino acid sequence Lys-Ile-Lys- Thr-Lys-Lys from the 27th term. The TCF-II variant using Ala-Ile-Ala-Thr-Ala-Ala is used. |
| priorityDate |
1997-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |